QualityStocks would like to highlight ScripsAmerica (
OTCBB: SCRC). The company provides a strong low cost system of broad base US national marketing, sales, and distribution of generic Rx, branded Rx, OTC, nutraceuticals, and oral delivery OTC pharmaceuticals through mass merchants, super markets, chain drug stores, independent drug stores, hospitals, long term care, HMO’s, home health care, clinics, PBM’s, State and Federal Government (Department of Veterans Affairs, Department of Defense).
In the company’s news,
ScripsAmerica has entered into talks with Forbes Investment Ltd. to market, supply, distribute, and adapt ScripsAmerica’s RapiMed® products throughout China.
Jun Liang, manager of Forbes Ltd. in Shenzhen, China, is making arrangements for ScripsAmerica to meet with the investment group’s pharmacy and hospital buying networks as part of an upcoming sales agreement that would introduce RapiMed into the Chinese OTC drug market.
“ScripsAmerica’s RapiMed Products are uniquely formulated to meet China’s market needs. It allows the country’s pharmaceutical companies, hospitals, nursing facilities, research institutes and the military to adapt RapiMed to fit their situations,” Lang stated in the press release. “With children making up over 17 percent of China’s nearly 1.5 billion population, RapiMed for children will be a target market of the company’s initial sales penetration. With the tablets ease to administer without the need for water, simple packaging for retail sales, precise dosing, and bulk distribution, it has spurred the interest beyond the children’s market. Forbes believes that the company’s product technology can be adapted for medications ranging from pain to diabetes.”
Liang also noted two additional markets that hold“enormous sales potential” for ScripsAmerica’s technology: retailing and distributing erectile dysfunction products and sales to the military.
“One in three Chinese men displays some symptoms of ED. This translates into almost one hundred million men and the perfect opportunity for the ‘Quickmelt’ technology of RapiMed to gain acceptance throughout this vast country …. We [also] believe that the technology of RapiMed has great potential for deployed personnel in normal and difficult field situations,” said Liang.
Formal sales and marketing negotiations will take place later this month, followed by technology protection agreements – Forbes said that it expects the formal exchange of agreements to be finalized before the end of September.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit
www.QualityStocks.com
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
